Feline GM-CSF ELISpot Kit from R&D Systems

Goat Anti-Human SCP3 / SYCP3 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems

Rabbit Anti-Human ADH5 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.

Mouse Anti-Human Rad1 Monoclonal Antibody, Unconjugated, Clone 33 from R&D Systems

Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides from Molecular Probes (Invitrogen)

Goat Anti-Human SCP3 / SYCP3 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems Rabbit Anti-Human ADH5 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.Mouse Anti-Human Rad1 Monoclonal Antibody, Unconjugated, Clone 33 from R&D Systems Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides from Molecular Probes (Invitrogen)

(Date:11/26/2009)...ers, red deer have been caught in the hunters, sig... more than decorative. They are lethal weapons tha... from The University of York, UK, has been intrigu...alf a century and has become fascinated by the mec...ng collaboration with Tomas Landete-Castillejos at...

(Date:11/26/2009)...phylococcus Aureus ) and other drug-resistant bact...asma prototype devices have been developed to offe...ktails. , Two prototype devices have been develo...n (e.g. hands and feet) in hospitals and public sp...another to shoot bacteria-killing agents into infe...

(Date:11/25/2009)... Cell Death Research Laboratory in the University ... the prestigious Johnson & Johnson Focused Funding...in cell damage in Parkinson,s disease. The award, ...t of innovation and excellence in science, was ann...his month at an event at the Hyatt Regency Hotel i...

Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2 Plasma produces KO cocktail for MRSA 2 Plasma produces KO cocktail for MRSA 3 Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2 New Media Led Effort Responds to AIDS Crisis in Black America 50086 1 New Media Led Effort Responds to AIDS Crisis in Black America 50086 2 New Media Led Effort Responds to AIDS Crisis in Black America 50086 3 New Media Led Effort Responds to AIDS Crisis in Black America 50086 4 New Media Led Effort Responds to AIDS Crisis in Black America 50086 5 New Media Led Effort Responds to AIDS Crisis in Black America 50086 6 Abused Kids Face Higher Cancer Risk 50083 1 Abused Kids Face Higher Cancer Risk 50083 2 U M study finds voice box can be preserved even with the largest cancers 50080 1 U M study finds voice box can be preserved even with the largest cancers 50080 2

[2] Tough yet stiff deer antler is materials scientist's dream [0] Plasma produces KO cocktail for MRSA [0] Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's

...gy infrastructure for researching and developing n...e industry hundreds of millions of dollars annuall... the National Institute of Standards and Technolog...T, the studys authors found that over the last two...ted from small-molecule chemicals to large-molecul...

...archers contributed to a national effort to sequen...hat will help advance research in a broad range of... to understanding a variety of human diseases. , ...ectionately as Chlamy, has long fascinated scienti...s that retains characteristics of both. Like green...

...greatly improves the ability to separate global wa...e gas is prepared for use, according to engineers ...yzed the new plastics performance. , Like a spong...astic permits carbon dioxide or other small molecu...t, while impeding natural gas (methane) movement t...

Other Biology News:Biopharmaceutical infrastructure key to lower drug development costs 2 'Chlamy' genome holds clues for renewable energy, the environment and human health 2 New membrane strips carbon dioxide from natural gas faster and better 2 New membrane strips carbon dioxide from natural gas faster and better 3

Biopharmaceutical infrastructure key to lower drug development costs 'Chlamy' genome holds clues for renewable energy, the environment and human health New membrane strips carbon dioxide from natural gas faster and better

(Date:11/30/2009)...RK, Nov. 30 The Michael... today announced $1.5 million in total awards to s...isease-modifying therapies for Parkinson,s disease...hes to Drug Discovery for Parkinson,s Disease pro...on, plc (NYSE: ELN ), a neuroscience-based biote...

(Date:11/30/2009)...STERDAM, November 30 Biopharmaceut...e first patients have been enrolled in its,multina...The study is,designed to show reduction in transpl...ng an allogeneic stem cell transplantation with a ... patients eligible for an allogeneic,stem cell tra...

(Date:11/30/2009)...LLE, Md., Nov. 30 Novava...mpleted enrollment in the Phase II clinical study ...ommended strains) VLP vaccine candidate in healthy...This randomized, double-blind, active-controlled s...unogenicity of two different doses (15 mcg and 60 ...

(Date:11/30/2009)...EATTLE, Nov. 30 Cell The...nced today that its new class of platinum-based an...rated a stronger anti-tumor potency and activity c...ounds as well as the ability to overcome cisplatin...e presented in a paper titled "Novel Bis-platinum ...

Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2 The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3 Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2 NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2 NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3 NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4 New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2 New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3

[0] The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments [0] Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)[0] NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults [0] New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents

Products	Feline GM-CSF ELISpot Kit from R&D Systems
Company	R&D Systems
Item	Feline GM-CSF ELISpot Kit
Price	$440.00
Description	Request Info
Info	R&D Systems R&D Systems, Inc. 614 McKinley Place N.E. Minneapolis, MN 55413 Customer Service: 1 (800) 343-7475 1 (612) 379-2956 Fax Number: 1 (612) 656-4400 Web Site: http://www.rndsystems.com